A genetic roadmap to the response to genotoxic agents in human cells

Alberto Ciccia1, Roger A Greenberg2, Susan P Lees-Miller3

  • 1Columbia University Irving Medical Center.

Faculty Reviews
|December 19, 2022
PubMed

Insights

Researchers used a CRISPR screen to find genes affecting cancer drug sensitivity. This study reveals new DNA repair pathways crucial for cancer therapy and understanding genome stability.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Cellular DNA damage repair is vital for genome stability and preventing diseases like cancer.
  • Cancer treatments often involve DNA-damaging agents (chemotherapy, radiation), necessitating understanding of cellular responses.
  • Identifying genes that influence sensitivity or resistance to these agents is critical for effective cancer therapy.

Purpose of the Study:

  • To identify genes involved in DNA damage response pathways.
  • To discover novel genetic factors that modulate sensitivity or resistance to various DNA-damaging agents used in cancer treatment.

Main Methods:

  • Utilized a CRISPR-based genetic screen.
  • Tested the impact of gene disruptions on cellular responses to 27 different DNA-damaging agents.
  • Analyzed results to identify genes regulating DNA damage repair pathways.

Main Results:

  • Identified multiple previously unknown genes that influence sensitivity or resistance to DNA-damaging agents.
  • Revealed new connections within critical DNA damage repair pathways.
  • Provided a comprehensive dataset of genetic modulators of DNA damage response.

Conclusions:

  • The findings offer new insights into fundamental DNA repair mechanisms.
  • Identified genes have potential as therapeutic targets or biomarkers for cancer treatment.
  • Results have significant implications for both basic science research and clinical applications in oncology.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.7K
Overview of DNA Repair02:25

Overview of DNA Repair

7.7K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
DNA Damage Can Stall the Cell Cycle02:37

DNA Damage Can Stall the Cell Cycle

2.7K
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
96